Anything you can do, glycans do better: deglycosylation and noncanonical ubiquitination vie to rule the proteasome. [PDF]
Lehrbach N.
europepmc +1 more source
Structural characterization of zebrafish Ngly2, an ovary-enriched acid PNGase required for egg-free glycan production. [PDF]
Honda A +11 more
europepmc +1 more source
Glycosylation disorders in pediatric epilepsy: pathophysiology, imaging and precision therapy. [PDF]
Fan L, Shen Y, Wang J, Gan J.
europepmc +1 more source
AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases. [PDF]
Amniouel S, Shyr ZA, Mathé EA, Zheng W.
europepmc +1 more source
Related searches:
Delineating the epilepsy phenotype of
Abstract We delineated the phenotypic spectrum of epilepsy in individuals with NGLY1 deficiency from an international cohort. We collected detailed clinical and electroencephalographic data from 29 individuals with bi‐allelic (likely) pathogenic variants in NGLY1 as part of an ongoing prospective natural history study.
Rebecca J. Levy +4 more
openaire +2 more sources
Expanding the NGLY1 Deficiency Phenotype: Case Report of an Atypical Patient
European Journal of Medical Genetics, 2022NGLY1 deficiency is a rare congenital disorder of deglycosylation with a unique constellation of symptoms that include hypo- or alacrima, movement disorder, epilepsy, and severe intellectual disability (OMIM #615273). Here we report a patient with NGLY1 deficiency whose clinical presentation lacks many of the features associated with the disease and ...
Kim L. McBride, Daniel Nolan
exaly +3 more sources
Comparative proteomics reveals elevated CCN2 in NGLY1-deficient cells
Biochemical and Biophysical Research Communications, 2022N-glycanase 1(NGLY1) catalyzes the removal of N-linked glycans from newly synthesized or misfolded protein. NGLY1 deficiency is a recently diagnosed rare genetic disorder. The affected individuals present a broad spectrum of clinical features. Recent studies explored several possible molecular mechanisms of NGLY1 deficiency including defects in ...
Rebecca Hetz +6 more
openaire +2 more sources
NGLY1 Deficiency: A Prospective Natural History Study (NHS)
2023Abstract N-glycanase 1 (NGLY1) Deficiency is a debilitating, ultra-rare autosomal recessive disorder caused by loss of function of NGLY1, a cytosolic enzyme that deglycosylates other proteins. It is characterized by severe global developmental delay and/or intellectual disability, hyperkinetic movement disorder, transient elevation of ...
Sandra Tong +10 more
openaire +1 more source
A commentary on ‘Patient-derived gene and protein expression signatures of NGLY1 deficiency’
The Journal of Biochemistry, 2023Abstract The cytosolic peptide:N-glycanase (PNGase; NGLY1 in human and PNG1 in budding yeast) is a deglycosylating enzyme widely conserved in eukaryotes. Initially, functional importance of this enzyme remained unknown as the png1Δ mutant in yeast did not exhibit any significant phenotypes.
openaire +2 more sources
Ocular features of NGLY1 deficiency from a prospective longitudinal cohort
Journal of American Association for Pediatric Ophthalmology and StrabismusNGLY1 deficiency is a rare autosomal recessive disorder with core features of global developmental delay, liver enzyme abnormalities, movement disorder, polyneuropathy, and hypo- or alacrima. We characterized the full spectrum and evolution of the ocular phenotype in a prospective natural history of NGLY1 deficiency.We collected ophthalmological data ...
Christina H. Frater +5 more
openaire +2 more sources

